Management(Page)
Chief Executive Officer since: 2014 About: Dr. , has a PhD in Neurobiology, from the Weizmann Institute of Science, and was a postdoctoral at ...

Proof of concept(Page)
Proof of concept studies in animal model and humans Pre-clinical studies Medicortex has performed preclinical research comparing fluid biopsie...

Management(Page)
Chief Executive Officer since: 2014 About: Dr. , has a PhD in Neurobiology, from the Weizmann Institute of Science, and was a postdoctoral at ...

Management(Page)
Chief Executive Officer since: 2014 About: Dr. , has a PhD in Neurobiology, from the Weizmann Institute of Science, and was a postdoctoral at ...

Corporate Governance(Page)
Corporate Governance Follow the links below to find out more: Corporate Governance...

Scientific and Clinical Advisory Board(Page)
c health. He is an experienced clinician and scientist with international experience in project leading. Dr. Kvist recently retired from his p...

Board of Directors(Page)
the Board Board member since: 2014 Education: PhD Neurobiology, Weizmann Institute of Science, Israel. Post Doctorate, Washington University ...

Board of Directors(Page)
the Board Board member since: Education: PhD Neurobiology, Weizmann Institute of Science, Israel. Post Doctorate, Washington University Schoo...

Medicortex has published a company release: IPO and listing cancelled(News)
style="">Medicortex announces cancellation of the Initial Public Offering (IPO) and listing to the First North Growth Market Finland mar...

Drug development program(Page)
Drug molecule development NCE project will be our next mission New Chemical Entities (NCEs) The Company has designed several chemically verifi...

Medicortex in Science and Enterprise(News)
font-weight: 400;">in Science and Enterprise about Medicortex and the R&D grant from the US Department of Defense...

Medicortex wins the Life Science Pitching competition at Y Science 2019 (News)
participated in Life Science pitching competition at Y Science 2...

Dr. Harel is the Face of the Month in Turku Science Park's Newsletter(News)
of the Month in Turku Science Park's Newsletter Israeli neurobiologist Adrian Harel founded in Turku a company called Medicortex Finland w...

Traumatic brain injury (Page)
CT) scans, magnetic resonance imaging (MRI) scans or neurological examination which are not always accurate to correctly diagnose mild and mod...

Dr. Harel attended the 7th International Conference on Biochemical Markers for Brain Damage(News)
ext">BMDB 2015 conference in Lund, Sweden from September 14th to the 16th. The conference included commercial and academic interaction...

Medicortex Finland Announces Agreement with Pro-Lab / Yhteistyösopimus Pro-Lab:n kanssa(News)
n/Medicortex-Finland-Announces-Agreement-Pro-Lab" class="aloha-link-text" target="_blank">Press Release.Medicortex on tehnyt yhteis...

Medicortex Finland Oy Announces Issuance of a Patent for Brain Injury Biomarker(News)
edicortex-Finland-Oy-Announces-Issuance-Patent-Brain" class="aloha-link-text" target="_blank">See press release...

Medicortex Finland Oy announces reaching the halfway point in the clinical trial for children and adolescents.(News)
edicortex-finland-oy-announces-the-advancement-in-clinical-trial-for-detection-of-mild-traumatic-brain-injury-in-children?publisherId=49600577...

Medicortex and Dividend Announce a Pre-IPO Investment / Medicortex ja Dividend Julkistavat Ennakko-IPO Sijoituksen(News)
icortex-and-Dividend-Announce-a-Pre-IPO-Investment" class="aloha-link-text" target="_blank">Read the press release here. Divid...

Last Reminder to Holders of Incentive Options(News)
option holders who hold incentive options issued before June 2022, to exercise the options (convert to shares) no later than 16 December 2...

Reminder to register attendance for AGM(News)
uld register their attendance by 16th of April 4pm Finnish time.More information...

Team(Page)
s a PhD in Biological Sciences from Vanderbilt University in Nashville, TN, USA. She has key experience in life sciences R&D project managemen...

Dr. Adrian Harel Presented TBI at Life Sciences Israel 2015(News)
href="http://www.lifesciencesisrael.com/" class="">here...

Dr. Kvist attending Clinical Trials Excellence Forum 2016(News)
in Clinical Trials Excellence Forum 2016 (12. - 14. October, Munich)...

Dr. Harel will attend the European Life Sciences CEO Forum(News)
Annual European Life Sciences CEO Forum & Exhibition.The event will take place on 6th to 7th March 2017 in Zurich, Switzerland...

Medicortex Announces Receiving a 1.1 Million Dollars Research Grant from the US Department of Defense / Medicortex Finland Oy:lle tutkimusrahoitusta Yhdysvaltain Puolustusministeriöltä(News)
005178/en/Medicortex-Announces-Receiving-1.1-Million-Dollars-Research" class="aloha-link-text" target="_blank">press release for detailed...

Medicortex Announces Progression in the Clinical Trial for Detection of Mild Traumatic Brain Injury in Children(News)
edicortex-finland-oy-announces-the-progression-of-clinical-trial-for-detection-of-mild-traumatic-brain-injury-in-children?publisherId=49600577...

Medicortex has published a company release: The Finnish Financial Supervisory Authority has approved a supplement to the Prospectus(News)
sttinfo.fi/embedded/announcement?publisherId=49600577&announcementId=2198&widget=true" class="aloha-link-text" target="_blank">compan...

Medicortex on julkaissut yhtiötiedotteen: Finanssivalvonta on hyväksynyt Esitteen täydennyksen(News)
sttinfo.fi/embedded/announcement?publisherId=49600577&announcementId=2197&widget=true" class="aloha-link-text" target="_blank">yhtiöt...

Business Strategy(Page)
dent site or in the ambulance. The hospital will be prepared as soon as the patients arrives. Medicortex test can be used to discover soldier...

Medicortex Finland Is Developing Diagnostic Tool Based on Biomarkers for Traumatic Brain Injury and Stroke(News)
ot only diagnose the presence of a brain injury, it will also quantify its severity and indicate the treatment needed. In addition, the kit co...

Patent issued in Canada / Patentti myönnetty Kanadassa(News)
We are happy to announce that the Canadian Patent Office has granted a patent for our core technology in biomarker diagnostics. Please see...

Medicortex has published a company release announcing that the US Department of Defense has approved Company’s project plan(News)
style="">Medicortex announces that the US Department of Defense (DoD) has approved Company’s project plan to develop a test strip detecting b...

Second clinical trial(Page)
ere analysed for the precence of the biomarker.  Sample analysis showed statistically significant increase in biomarker level.  2nd Clinical T...

The TBI Market(Page)
uch as Chronic Traumatic Encephalopathy (CTE). Unfortunately, mTBI goes often undiagnosed since current detection methods that are based on he...

Patent Issued in Israel / Patentti Israelissa(News)
edicortex-Finland-Oy-Announces-Issuance-Patent-Israel" class="aloha-link-text" target="_blank">Press Release.Israelin valt...

Medicortex on julkaissut yhtiötiedotteen, jossa ilmoittaa Yhdysvaltain puolustusministeriön hyväksyneen hankesuunnitelman(News)
sttinfo.fi/embedded/announcement?publisherId=49600577&announcementId=2197&widget=true" class="aloha-link-text" target="_blank">https:...

Medicortex on julkaissut yhtiötiedotteen: listautumisanti ja listautuminen perutaan(News)
tps://www.sttinfo.fi/announcement?publisherId=49600577&announcementId=2586" class="" target="_blank">https://www.sttinfo.fi/announcement?p...

Company Profile(Page)
in the heart of Turku Science Park. The company has received funding from Business Finland, twice from United States Department of Defense, Ho...

Technology(Page)
equire increased surveillance, or for those individuals with mild TBI, who otherwise may remain undiagnosed and untreated. A diagnostic test c...

Why invest?(Page)
directors include experienced leaders with experience in the pharmaceutical and biotech industry, drug development, GMP production and ma...

Biomarker R&D program(Page)
ed, for example, the presence of the novel biomarker in mild TBI, specificity to TBI and its time-related appearance after the injury, and val...

General Meetings(Page)
dates and  compulsory advance enrollment. Yhtiokokous 26 4 2024 Annual General Meeting Medicortex Tilinpaatos 2023 Ja Tilintarkastus Medicorte...

Letter from CEO(Page)
ts relatively high prevalence. Today, there are no accurate, widely approved diagnostic tools to detect TBI unambiguously. Neurological examin...

Why Invest?(Page)
ble of telling the difference between a TBI case and a healthy person. Addressing a Critical Need: Recognizing the pressing need for effici...

Letter from CEO(Page)
ts relatively high prevalence. Today, there are no accurate, widely approved diagnostic tool to detect TBI unambiguously. Neurological examina...

Drs. Harel & Kvist attended the BAF Live! event in Helsinki on 22nd of October(News)
Live! people at the residence of the Dutch Ambassador, Cees Bansema, on 22nd of October. Photo taken and copyrighted by Replay Factory. Drs...

Tom Palenius joins Medicortex's Board of Directors(News)
ng activities of Life Science business...

Results of the First Clinical Study are Published in Frontiers in Biomarkers of Brain Injury(News)
n Injury of the Brain Sciences journal. The article summarizes results from the first clinical study. You can read the open access article...

Articles of Association(Page)
the Company of its attendance as indicated in the notice and by the date specified in the notice, which may not be earlier than ten (10) days ...

Hallitus(Page)
Weizmann Institute of Science, Israel). Kauppatieteiden maisteri (University of Haifa, Israel). Postdoc (Washington University School of Medic...

Hallitus(Page)
Weizmann Institute of Science, Israel). Kauppatieteiden maisteri (University of Haifa, Israel). Postdoc (Washington University School of Medic...

Miksi sijoittaa?(Page)
en tutkimus ja proof-of-concept tutkimus ihmisillä). Yhtiö on suorittanut kolme kliinistä tutkimusta, joissa merkkiaine löydettiin. Ensimm...

Approval of a patent for a drug candidate / Lääkemolekyylipatentti hyväksytty(News)
n/Medicortex-Finland-Announces-Patent-Approval-Underlying-Technology" class="aloha-link-text" target="_blank">Press Release.Medicor...

Major achievement – A patent was issued in the United States (News)
edicortex-finland-oy-announces-issuance-of-a-patent-in-the-united-states?publisherId=49600577&releaseId=69889303" class="aloha-link-text"...

Merkittävä saavutus – Medicortexille myönnettiin patentti Yhdysvalloissa (News)
edicortex-finland-oy-announces-issuance-of-a-patent-in-the-united-states?publisherId=49600577&releaseId=69889303" class="aloha-link-text"...

Patent granted in Israel(News)
edicortex-finland-oy-announces-issuance-of-a-patent-in-israel?publisherId=49600577&releaseId=69927055" class="aloha-link-text" target="_bl...

Annual General Meeting / Yhtiökokous (News)
e Company of their attendance by 8 April 2022 at 4:00 p.m. Finnish time by email to medicortex@medicortex.fi or by phone to +358 400 870&n...

In the press: Turun Sanomat has published an article about Medicortex(News)
tps://www.sttinfo.fi/announcement?publisherId=49600577&announcementId=2198" class="" target="_blank">Company Release regarding DoD's a...

Medicortex lehdistössä: Turun Sanomat julkaissut artikkelin(News)
tps://www.sttinfo.fi/announcement?publisherId=49600577&announcementId=2197" class="" target="_blank">yhtiötiedotetta Yhdysvaltain puol...

Clinical trials(Page)
ntly running a proof-of-concept clinical trial in collaboration with Turku University Hospital (Tyks). Samples from 12 head-injured patients a...

Johtoryhmä(Page)
Weizmann Institute of Science, Israel) sekä kauppatieteiden maisteri (University of Haifa, Israel). Harelilla on useiden vuosien kokemus lääke...

Company Profile(Page)
in the heart of Turku Science Park. The company has received funding from Business Finland, twice from United States Department of Defense, Ho...

Auditor(Page)
Accountant (KHT) | Assurance & Advisory Mobile: +358 (0)40 670 6772  Email: riku.vuorinen@fi.gt.com Grant Thornton Advico Finland Oy  Veistäm...

Johtoryhmä(Page)
Weizmann Institute of Science, Israel) sekä kauppatieteiden maisteri (University of Haifa, Israel). Harelilla on useiden vuosien kokemus lääke...

Financial and Developmental Timeline(Page)
that includes proof-of-concept. Financial and Developmental Timeline...

Art Helping TBI Research(News)
an alternative way to finance our research & development program for a Brain injury diagnostic kit based on biomarkers and in the future d...

Medicortex's Annual General Meeting on May 30th(News)
ke place in the Turku Science Park Bioincubator on the 30th of May. All shareholders are invited to take part in the meeting...

The First Clinical Trial is Approaching(News)
the Q4 of 2016. The presence and the profiles of the unique biomarkers will be studied and compared between head injured patients and healthy...

Extraordinary general meeting 29th September(News)
t 5.00 p.m. in the conference room of the Bioincubator (PharmaCity, Itäinen pitkäkatu 4 B, 4th floor, Turku, Finland).It's possible to...

Medicortex has completed collection of clinical samples(News)
We are happy to announce that we have completed the collection of clinical TBI patient samples in collaboration with Turku University Hosp...

Medicortex has launched a crowdfunding campaign(News)
wdfunding campaign to finance the next phase development of the brain injury test. You can help us to develop a rapid diagnostic kit for brain...

Clinical Trial Result Marks a Significant Accomplishment for Medicortex Finland(News)
a significant proof-of-concept and it represents a remarkable milestone for Medicortex. Please see the ...

Medicortex's Annual General Meeting on May 29th(News)
ke place in The Turku Science Park Bioincubator on the 29th of May 2017 at 15:00. All current shareholders are invited to take part and attend...

A New Clinical Trial for a Novel Brain Injury Biomarker(News)
land Oy was granted clearance to begin a multi-center clinical trial. The trial will consist of patients that are admitted to emergency rooms...

New Clinical Trial Started / Kliininen tutkimus alkanut(News)
Medicortex announces that the first subject has been enrolled in the new clinical trial. Please see the...

The second brain injury awareness meeting 12.2.2018(News)
told us about his experience in the drug development field and about the spirit that is needed to build up a successful biotech startup in a...

Medicortex was accepted to the European Union Horizon 2020 funding program (News)
ludes a larger sum to enhance activities further. Medicortex hyväksyttiin EU:n...

Medicortex presenting in an investors seminar / Medicortex esiintyi Turussa sijoittajatapahtumassa (News)
well received by the audience. We value this opportunity greatly. Medicortex esiintyi Turussa osakesäästäjien keskusliito...

Medicortex was chosen as the winner of TechBBQ’s pitching competition! (News)
We had a fantastic experience! ...

Medicortex presented at LSX World Congress in London(News)
o the leaders of life science industry. LSX World Congress brings together the healthcare executives, global investors and biotech a...

Detecting sport concussions with a disposable quick-test developed by Medicortex (News)
ave life-changing consequences. However, detecting concussions after an injury is difficult. That´s why we are focused on developing a easy-to...

Completion of the Third Clinical Trial - an Important Achievement for Medicortex Finland(News)
the samples for the presence of the unique biomarkers for traumatic brain injuries. ...

Press Release / Lehdistötiedote(News)
lank">Press Release concerning Medicortex.Mediocortexiin liittyvä uusi...

Medicortex Signed a 2 Million Dollars Research Grant Contract with the US Department of Defense(News)
tex Finland Plc announces that the US Department of Defense (“DoD”) has awarded the company a research grant of about 2 million dollars f...

Annual General Meeting(News)
nvestors/corporate-governance/general-meetings/" class="aloha-link-text" target="_blank">here...

Medicortex was granted a European patent for biomarker diagnostics(News)
e or saliva, for the presence and the level of biomarkers that are indicative of TBI.Read the press release ...

Medicortex receives extension to Business Finland funding decision(News)
Medicortex announces receiving an extension for raising the starting equity required by the funding decision from Business Finland. The fu...

Still a little time left to raise Business Finland decision's initial capital!(News)
Our previous announcements on the matter:...

Annual General Meeting(News)
nvestors/corporate-governance/general-meetings/" class="aloha-link-text" target="_blank">here...

The 24th Annual Israel Society for Neuroscience Meeting(News)
Dr. Adrian Harel will be attending and presenting a poster session at the 24th annual ISFN meeting in Eilat on the 20th to 22nd o...

Medicortex participated in a press conference #pääasia(News)
Medicortex's medical director Mårten Kvist participated on a panel discussion of #pääasia- media event 7.11. in Biocity Turku. Fo...

Medicortex Finland Plc has published a press release regarding announcement of IPO(News)
Medicortex has published a press release announcing its intention to launch an initial public offering (IPO) and apply for listin...

Medicortex Announces a Fundraising Campaign (extended to 19 July)(News)
Update 17 July 2022: Subscription period extended to 19 July 2022 due to fair demand and vacation season - so that everybody cons...